Abingdon Health and DCN Diagnostics have announced a commercial partnership to provide Abingdon Health’s proprietary AppDx Smartphone m-Health technology to DCN Diagnostics’ customer base.

CHARLESTON, S.C. and OAKDALE, Minn., March, 13 2020, - Veravas, Inc., an emerging diagnostic company focusing on sample preparation products and new diagnostic tests and MIP Diagnostics Ltd., the Molecularly Imprinted Polymers (MIPs) specialist based in Sharnbrook, United Kingdom, announced today that they have entered into a mutually beneficial agreement for the development, license, and supply of a novel MIP specific for Veravas’ proprietary sample preparation technology.

New RNA Complete BCT™ is a direct draw blood collection tube, now available in the UK from Alpha Laboratories Ltd. These blood collection tubes contain a preservative that stabilises cell-free RNA and exosome counts, maintaining the draw time concentration for up to 7 days when stored at room temperature.

A recent review by MIP Diagnostics Founder Sergey A. Piletsky from the University of Leicester and colleagues from Animal Health Research Institute (AHRI), Agricultural Research Center (ARC), Egypt, Beni-Suef University, and Linnaeus University in the International Journal of Molecular Sciences highlights recent developments in the technology-driven shift in MIP research from traditional bulk polymer formats into the nanomaterial domain, the current state of molecular imprinting, and its potenti...

Following a year of strong growth and successful acquisitions, Entrust People and SCI Search & Selection are merging to become Entrust Resource Solutions.

A New Standard of Excellence in Your Application

SureSeq™ CLL + CNV - comprehensive CLL genomic profiling from a single assay

Symposium highlights successful use of EKF’s Hemo Control hemoglobin analyzer in extreme environmental conditions

Robust panel enables accurate and comprehensive constitutional genetic aberration screening in one assay

Following a successful 2019, Abingdon Health is expanding its York-based facility, giving the company the space and capabilities necessary to continue to drive forward rapid diagnostic testing innovation and growth.